[Federal Register Volume 81, Number 122 (Friday, June 24, 2016)]
[Notices]
[Page 41320]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-14914]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Government-Owned Inventions; Availability for Licensing

AGENCY: National Institutes of Health, Department of Health and Human 
Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The inventions listed below are owned by an agency of the U.S. 
Government and are available for licensing in the U.S. in accordance 
with 35 U.S.C. 209 and 37 CFR part 404 to achieve expeditious 
commercialization of results of federally-funded research and 
development.

FOR FURTHER INFORMATION CONTACT: Licensing information may be obtained 
by emailing the indicated licensing contact at the National Heart, 
Lung, and Blood, Office of Technology Transfer and Development Office 
of Technology Transfer, 31 Center Drive, Room 4A29, MSC2479, Bethesda, 
MD 20892-2479; telephone: 301-402-5579. A signed Confidential 
Disclosure Agreement may be required to receive any unpublished 
information.

SUPPLEMENTARY INFORMATION: Technology description follows.
    Murine Cell Models for Metastatic Squamous Cell Carcinoma Two cell 
lines isolated from Pam 212 cells (SCC): Pam LY (lymph node metastasis) 
and Pam LU (lung metastasis) from metastated in vivo growth in mouse. 
These stably established cell lines exhibited higher potential to 
metastasize to lymph nodes and lungs, respectively, in mouse models 
than their parental Pam 212 cells.

Potential Commercial Applications

 Drug discover for squamous cell carcinoma
 Drug discover for squamous cell carcinoma metastated to lung 
and lymph nodes

    Inventors: Zhong Chen and Carter Van Waes (both of NIDCD).
    Intellectual Property: HHS Reference No. E-213-2016/0--Research 
Material.
    Licensing Contact: Michael Shmilovich, Esq, CLP; 301-435-5019; 
[email protected].

    Dated: June 17, 2016.
Michael Shmilovich,
Senior Licensing and Patenting Manager, National Heart, Lung, and Blood 
Institute, Office of Technology Transfer and Development.
[FR Doc. 2016-14914 Filed 6-23-16; 8:45 am]
 BILLING CODE 4140-01-P